






























































310 Infection 30 · 2002 · No. 5 © URBAN & VOGEL
Infection Case Report
Aerococcus urinae Endocarditis:
Case Report and Review of the Literature
C. Ebnöther, M. Altwegg, J. Gottschalk, J.D. Seebach, A. Kronenberg
Abstract
Aerococcus urinae is a rare cause of urinary tract infections,
mainly in elderly men with underlying urinary tract
pathologies. In addition, it has been described as a
pathogen in balanitis, soft tissue infections, septicemia and
endocarditis. To date ten cases of A. urinae endocarditis
have been reported in the literature with a high rate of
mortality (7/10) and morbidity, as two out of three survivors
suffered from neurovascular complications. Here we present
the case of an additional patient who was successfully
treated with surgical valve replacement and antibiotic
therapy consisting of ceftriaxone and netilmicin for 6 weeks.
Furthermore, we review all reported cases of A. urinae
endocarditis  with emphasis on predisposing factors and
therapeutic options.
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Introduction
For many years the genus Aerococcus comprised the single
species Aerococcus viridans, which was isolated from a
broad range of habitats but rarely has been associated with
human infections [1]. Aerococcus urinae was first described
as an Aerococcus-like organism (ALO) by Colman et al. in
1967 [2] and was found to differ from A. viridans by 16s
rRNA sequencing [3]. A. urinae is mainly responsible for
urinary tract infections, where it accounts for 0.3 – 0.8% of
all cases [4, 5]. A. urinae is also a pathogen reported in bal-
anitis [6], soft tissue infection [6], empyema [2], bacteremia
and endocarditis [5, 7, 8]. Between 1987 and 1994 the over-
all incidence of bacteremia associated with ALO in Den-
mark was 0.5 cases per million inhabitants per year [7].
Here we present the first case of an A. urinae endocarditis
diagnosed by broad-spectrum polymerase chain reaction
(PCR) of the resected valve specimen.
Case Report
A 75-year-old man was admitted to our tertiary care hospital with
blood culture negative aortic valve endocarditis for valve re-
placement. Three months earlier he had been treated as an out-
patient with ciprofloxacin for dipstick-positive urinary tract in-
fection for 7 days; urine culture was not done at this time. After 1
week a urinary retention due to urethrastenosis and phimosis was
treated with transabdominal catheterization.The patient was pre-
scribed ciprofloxacin prophylactically. A urine specimen did not
show pyuria and urine cultures again were not performed. 50 days
before admission to our hospital, urinary tract obstruction was cor-
rected surgically and ciprofloxacin was prescribed again prophy-
lactically; the catheter was removed after 10 days and ciprofloxacin
was stopped. The patient remained asymptomatic for 20 days be-
fore he suddenly suffered from chills and fever up to 39 °C. He im-
mediately was admitted to the urologic department of another
hospital (20 days prior to admission to our hospital) and was
treated with ciprofloxacin and netilmicin empirically on suspicion
of a urinary tract infection, although there was no pyuria. Urine
cultures were obtained only after start of the antibiotic therapy
and remained negative, blood cultures were not done.After initial
defervescence he became febrile again 7 days later and
ciprofloxacin/netilmicin were replaced by meropenem without
improvement.
Five days later a new systolic-diastolic murmur was noted at
the left sternal border and an indolent, blue to black flat lesion of
about 2mm diameter was detected paraunguinally on the right
fifth toe. The laboratory values were as follows: hemoglobin
10.2 g/dl, leukocytes 9.3  109/l, thrombocytes 266  109/l, C-reac-
tive protein (CRP) 180 µg/l and creatinine 118 mmol/l. The urine
sediment was normal, blood and urine cultures were negative as
well. Transesophageal echocardiography showed vegetations on
the aortic valve (Figure 1), CT of the abdomen a left kidney in-
farction and magnetic resonance imaging of the cerebrum, per-
formed because of hallucinations, multiple ischemic lesions. A di-
agnosis of infective aortic valve endocarditis with systemic em-
bolization was made. The causative microorganism, however, re-
mained obscure and antibiotic therapy was changed to flu-
cloxacillin, penicillin and netilmicin. Despite this therapy, the pa-
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tient remained febrile. Echocardiography was repeated 1 week
later and showed progressive destruction of the aortic valve,
whereupon the patient was transferred to our hospital.
At the day of admission to our hospital the antibiotic regimen
was modified as follows: netilmicin was replaced by gentamicin, flu-
cloxacillin 4  2 g iv was maintained, on suspicion of brain ab-
scesses, penicillin was replaced by ceftriaxone 2  2 g iv and
ciprofloxacin 2  750 mg po was added until the negative serologic
results for Coxiella burnetii, Bartonella spp. and Brucella meliten-
sis were available. With this therapy the patient became afebrile
and the CRP level dropped from 141 to 69 mg/l at day 8 after hos-
pitalization. Because of progressive aortic insufficiency valve re-
placement was performed 12 days after admission to our clinic. A
Gram stain of the valve specimen obtained from the operating
room showed predominantly gram-positive cocci with morphologic
variations, explainable by ongoing antibiotic therapy. However, cul-
tures of the valve remained negative, while amplification and di-
rect sequencing performed on DNA isolated from valve material,
as described by Goldenberger et al. [9], resulted in a 374 bp frag-
ment that perfectly matched an A. urinae sequence (accession num-
ber U64459) [9]. The next most closely related species was A. uri-
naehominis with 18 mismatches in a stretch of 350 nucleotides.
Upon this result, antibiotic therapy was simplified to ceftriaxone
22 g iv and netilmicin iv guided by drug levels which were con-
tinued for 6 weeks postoperatively.The further course of the patient
was unremarkable; 4 months later he was doing well with a good
prosthetic valve function and without any neurologic sequelae.
Discussion
A. urinae is a gram-positive, microaerophilic, catalase-neg-
ative, alpha-hemolytic coccus, growing predominately in
tetrads and clusters. In contrast to streptococci, it is capa-
ble of growing in 6.5% NaCl. Its growth on 5% sheep-blood
agar depends on incubation in CO2, therefore growth on
urine-dipslide agar is not reliable. This might explain dis-
crepancies between positive blood and negative urine cul-
tures in some cases [7]. Further underdiagnosis is possible,
as the database of the API 20 Strep system (Version 6.9;
API bioMérieux, Marcy l’Etoile, France), which has been
evaluated for identifiaction of streptococci associated with
infective endocarditis but does not contain A. urinae in the
database.This system may identify A. urinae as Streptococ-
cus acidominus with a high diagnostic likelyhood, but low
T values (which measure closeness to ideal phenotype of a
species). This constellation must raise the suspicion of a
wrong identification and mandates conventional testing or
molecular sequencing [10]. Differentiation from A. viridans
relies on positive reactions for leucine arylamidase and
beta-glucoronidase [3]. Besides A. viridans and A. urinae,
three additional Aerococcus species have been recently iso-
lated from the human vagina, Aerococcus christensenii [11],
and from human urine, A. urinaehominis and Aerococcus
sanguicola, respectively [12, 13]. However, the pathogenic
importance of these latter organisms remains unknown.
A total of eleven cases (including our patient) of A. uri-
nae endocarditis have been reported in the literature to date
(Table 1). Our patient presented with the typical predispos-
ing factors for A. urinae endocarditis which are male sex
(9/11), age > 65 (8/11) and preexisting urinary tract patholo-
gies (5/11), such as prostata hyperplasia, urethral stricture
and prior urinary tract surgery. The latter reflects that the
urinary tract is a potential port of entry for this organism.
Indeed, 6/11 patients were empirically treated for sympto-
matic urinary tract infections before diagnosis of A. urinae
endocarditis. Two frequently used antibiotics for urinary
tract infections, cotrimoxazole and quinolones, have no or
only moderate activity against A. urinae. Therefore, it is
probable that A. urinae may be selected during empiric ther-
apy with these drugs. As with all cases of infective endo-
carditis, preexisting valvular dysfunction is another risk fac-
tor, which was described in 3/11 patients, but was not docu-
mented in our case, although unrecognized sclerotic aortic
valves are common in this age-group. Remarkably, these
three patients had valvular pathologies with only moderate
risk for endocarditis, stressing the importance of other pre-
disposing factors. Finally, systemic comorbidities such as is-
chemic heart disease, diabetes mellitus and malignancy have
been proposed as risk factors for A. urinae endocarditis [4,
5, 8] and were present in 4/11 patients; this may, however,
just be due to the median age in this patient group.
Although its risk factor profile is quite characteristic,
A. urinae endocarditis is clinically indistinguishable from
endocarditis caused by other bacterial agents. It presents
with fever (9/11), a new heart murmur (7/11) and vegeta-
tions (8/11) (data not shown). Blood cultures are positive
in 10/11 patients. Occuring in 55% of the patients, systemic
embolization seems to be frequent, compared to only 20-
40% in infective endocarditis cases caused by other mi-
croorganisms [14]. This might be due to late diagnosis be-
cause of the subacute character of the disease and the of-
ten unspecific symptoms in the elderly. The establishment
of the etiologic diagnosis relied on positive blood cultures
in all but our patient, where blood cultures were performed
only after start of antibiotic treatment and remained nega-
Figure 1. Transesophageal echocardiography visualizes the vegeta-
tion on the aortic valve (white arrow). LV: left ventricle; RV: right ven-
tricle; AR: aortic root.
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tive. To the best of our knowledge this
is the first case of A. urinae endocardi-
tis where broad-spectrum PCR from a
surgically removed aortic valve led to
identification of the organism. In the fu-
ture this sensitive and specific method
could help identify even more cases of
A. urinae endocarditis, which may have
been missed so far because of negative
blood cultures.
Due to the rareness of A. urinae
endocarditis, controlled studies are not
possible and therefore antibiotic treat-
ment is not standardized. In vitro sus-
ceptibilities of 56 isolates showed little
inter-isolate variability with low mini-
mal inhibitory concentrations (MIC)
for penicillin, amoxicillin, piperacillin,
cefepime, vancomycin and rifampicin,
but variable MIC for ceftriaxone. No
isolate showed high-level aminoglyco-
side resistance [15]. Furthermore, syn-
ergy testing using time-killing curves
showed a synergistic bactericidal activ-
ity when penicillin or vancomycin were
combined with gentamicin [10, 15].
Treatment modalities were avail-
able for 10/11 patients.Although nine of
these patients were treated with a com-
bination of a beta-lactam and an amino-
glycoside, seven of them died. The re-
maining patient was treated with a beta-
lactam alone and survived with neuro-
logic sequelae. In all lethal cases death
occured during the first 4 weeks (mean
12 days). The optimal duration of ther-
apy for A. urinae endocarditis remains
to be defined. Nevertheless, we suggest
to treat all patients intravenously for a
minimum of 6 weeks, since all surviving
patients, including the presented pa-
tient, were treated for this time period
either with a beta-lactam alone or with
a beta-lactam and an aminoglycoside.
Surgical valve replacement does not
seem to be a prerequisite for cure, as
our patient was the first to undergo this
treatment.
As mentioned above, the prognosis
of A. urinae endocarditis is poor. More-
over, even if patients survive an A. uri-
nae endocarditis, morbidity is high since
3/4 survivors, including our patient, suf-
fered from neurologic sequelae after
cerebrovascular embolization. We sup-
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oligosymptomatic clinical presentation in elderly patients,
as well as comorbidities, contribute essentially to the ob-
served high early mortality and embolization rate.
In summary, A. urinae endocarditis is a severe disease
affecting mainly elderly men with urinary tract pathologies
and comorbidities. We suppose that late diagnosis due to
unspecific symptoms in the elderly and the difficulty to cul-
tivate the organism, as well as comorbidities, contribute to
the high morbidity and mortality. Antibiotic therapy with
beta-lactams for at least 6 weeks is effective if patients sur-
vive the 1st weeks of therapy. The addition of aminoglyco-
sides probably has a synergistic effect.
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